Doptelet found safe, effective in previously treated children with ITP
Doptelet (avatrombopag) was safe and effective in children with immune thrombocytopenia (ITP) who had an insufficient response to previous treatments, according to recently…
Immune thrombocytopenia
Hetrombopag is safe, effective for ITP in real-world settings: Study
Hetrombopag appears to be a safe and effective option in real-world settings for immune thrombocytopenia (ITP), with better outcomes linked with a higher starting…
